Senior Vice President
Thu, Aug 11, 2022
Aug 11
exercised or converted securities in APLS
5,000 shares @ $0.00
Decreased holdings by -50.00%
Net across this filing: 0.00% (+0 shares)
Option Exercise
Sale tied to a same-time option exercise
APLSApellis Pharmaceuticals, Inc.
HealthcareBiotechnology